These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6329835)

  • 1. Pathobiology of breast cancer--treatment implications.
    Vorherr H
    Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):219-35. PubMed ID: 6329835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of in situ breast cancer in a defined population.
    Temple WJ; Jenkins M; Alexander F; Hwang WS; Marx LH; Lees AW; Williams HT; Pambrun MG
    Ann Surg; 1989 Nov; 210(5):653-7. PubMed ID: 2554827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.
    Prescrire Int; 2013 Dec; 22(144):298-303. PubMed ID: 24600734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal breast cancer: advance or anachronism?
    Wolmark N
    Can J Surg; 1985 May; 28(3):252-5. PubMed ID: 2986808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ breast cancer: a multidisciplinary approach.
    Robert NJ; Wazer DE; Smith TJ; Homer MJ; Safaii H; Marchant DJ
    Hosp Pract (Off Ed); 1989 Apr; 24(4):169-76, 179-85. PubMed ID: 2538488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of minimal breast cancer.
    Veronesi U
    Semin Surg Oncol; 1989; 5(2):145-50. PubMed ID: 2543052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of minimal breast cancer: a pathologist's viewpoint.
    Wirman JA
    Crit Rev Oncol Hematol; 1985; 3(1):35-74. PubMed ID: 2990747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle-localized biopsy of occult breast lesions: an update.
    Snell MJ; Ostrow LB; DuBois JJ; Boyle LM; Calfee LW
    Mil Med; 1992 Feb; 157(2):61-4. PubMed ID: 1318524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentricity in nonpalpable breast carcinoma and its implications for treatment.
    Tinnemans JG; Wobbes T; van der Sluis RF; Lubbers EJ; de Boer HH
    Am J Surg; 1986 Mar; 151(3):334-8. PubMed ID: 3006532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive breast carcinoma.
    Posner MC; Wolmark N
    Breast Cancer Res Treat; 1992; 21(3):155-64. PubMed ID: 1325215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention.
    Simmons RM; Osborne MP
    Surg Oncol; 1999 Aug; 8(2):55-65. PubMed ID: 10732957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical management of a normal contralateral breast in patients with lobular breast cancer.
    Baker RR; Kuhajda FP
    Ann Surg; 1989 Oct; 210(4):444-7; discussion 447-8. PubMed ID: 2552945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
    Calabrese L
    Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ breast cancer.
    Henry-Tillman RS; Klimberg VS
    Curr Treat Options Oncol; 2000 Aug; 1(3):199-209. PubMed ID: 12057162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraductal carcinomas in situ. Retrospective study of 21 cases and review of the literature].
    Levêque J; Poulain P; Berger D; Broux PL; Grall JY; Giraud JR; Kérisit J
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):149-62. PubMed ID: 1649217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and survival of female patients with nonpalpable breast carcinoma.
    Tinnemans JG; Wobbes T; Holland R; Hendriks JH; Van der Sluis RF; De Boer HH
    Ann Surg; 1989 Feb; 209(2):249-53. PubMed ID: 2537064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lobular carcinoma of the breast in situ and infiltrating.
    Wheeler JE; Enterline HT
    Pathol Annu; 1976; 11():161-88. PubMed ID: 188001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of in situ ductal cancers of the breast].
    Rochet Y
    Rev Fr Gynecol Obstet; 1991 Nov; 86(11):666-8. PubMed ID: 1664138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.
    Hiramatsu H; Bornstein BA; Recht A; Schnitt SJ; Baum JK; Connolly JL; Duda RB; Guidi AJ; Kaelin CM; Silver EB; Harris JR
    Cancer J Sci Am; 1995; 1(1):55-61. PubMed ID: 9166455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.